Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM
Breadcrumb Trail Links Newsfile Article content Toronto, Ontario–(Newsfile Corp. – May 9, 2025) – Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) (“Neural” or the “Company“), an ethnobotanical drug discovery company focused on developing therapeutic drugs …